Microglial Modulation as a Therapeutic Avenue for Perioperative Neurocognitive Disorders: Unveiling Pathophysiological Mechanisms and Clinical Implications
CNS Neuroscience & Therapeutics · 2025-07 · 31 (7)
DOI: 10.1111/cns.70481 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.07.2025. Verfasst von Xizhen Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Affiliated People's Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Microglia, Neurocognitive Disorders, Postoperative Cognitive Complications. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Background
Perioperative neurocognitive disorders (PND) encompass a spectrum of cognitive impairments that arise from the preoperative phase and can persist for months after surgery, with a prevalence of up to 50% in elderly patients. These disorders, including postoperative delirium and sustained cognitive decline, significantly reduce patient quality of life and impose substantial burdens on healthcare systems. Despite extensive research, the underlying pathophysiological mechanisms remain inadequately understood, limiting the development of effective treatments. Increasing evidence highlights neuroinflammation as a central factor in PND, with microglia—the resident immune cells of the central nervous system—playing a key role in mediating inflammatory responses that lead to cognitive dysfunction.
Methods
This review comprehensively analyzes the role of microglia in the pathogenesis of PND. It details key perioperative triggers of microglial activation, such as surgical stress, anesthesia, and systemic inflammation. The review further examines preclinical interventions aimed at modulating microglial function, including depletion strategies, polarization toward anti‐inflammatory phenotypes, and inhibition of inflammatory pathways like NF‐κB and NLRP3.
Results
Preclinical studies demonstrate that dysregulated microglial activation results in excessive production of pro‐inflammatory cytokines, oxidative stress, and synaptic disruptions, which collectively contribute to neuronal injury and cognitive impairment. Interventions targeting microglial activation have shown efficacy in reducing neuroinflammation and preserving cognitive function in animal models.
Conclusions
Targeting microglial activation represents a promising strategy for alleviating PND. However, challenges remain in clinical translation, necessitating advanced drug delivery platforms, personalized therapeutic approaches, and rigorous clinical validation. Advances in microglial modulation hold potential for improving postoperative cognitive outcomes and enhancing patient recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
- Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Liu, X., & Zhang, A. (2025). Microglial Modulation as a Therapeutic Avenue for Perioperative Neurocognitive Disorders: Unveiling Pathophysiological Mechanisms and Clinical Implications. CNS Neuroscience & Therapeutics, 31(7). https://doi.org/10.1111/cns.70481
Vancouver
Liu X, Zhang A. Microglial Modulation as a Therapeutic Avenue for Perioperative Neurocognitive Disorders: Unveiling Pathophysiological Mechanisms and Clinical Implications. CNS Neuroscience & Therapeutics. 2025;31(7). doi:10.1111/cns.70481
BibTeX
@article{Liu2025,
author = {Liu, Xizhen and Zhang, Anke},
title = {Microglial Modulation as a Therapeutic Avenue for Perioperative Neurocognitive Disorders: Unveiling Pathophysiological Mechanisms and Clinical Implications},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {7},
doi = {10.1111/cns.70481}
}
EUVIMED